| Net income | 77.8M |
| Depreciation and amortization | 40.8M |
| Gain on settlement | 0 |
| Deferred income taxes | |
| Other, net | 2.5M |
| Receivables | -6.3M |
| Inventories | -159.9M |
| Accounts payable and accrued liabilities | -1.5M |
| Income taxes | -5.5M |
| Other, net | -20.4M |
| Net cash provided (used) by operating activities | -68.2M |
| Capital expenditures | -53.9M |
| Purchases | -15.8M |
| Proceeds from sale | 6.4M |
| Loans | |
| Collections of principal payments | |
| Other, net | 5.7M |
| Net cash used in investing activities | -31.3M |
| Treasury stock purchases | -1.4M |
| Common stock | -39.3M |
| Noncontrolling interest in subsidiary | 0 |
| Other, net | -100K |
| Net cash used in financing activities | 62M |
| Effect of exchange rate changes on cash | 900K |
| Net cash provided (used) during period | -36.6M |
| Cash and cash equivalents at beginning of period | 47.3M |
| Cash and cash equivalents at end of period | 10.7M |
| Supplemental disclosures of cash paid for income taxes | 42.2M |